Mladen Knotek

Mladen Knotek

Auto-generated profile, based on publicly available information

Mladen Knotek

University Hospital Crosshouse, Kilmarnock, UK

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2020 in Medicine
Verified
Journal Article
Open access
IMIvan Margeta
Ivan Margeta
IMIvana Mareković
Ivana Mareković
APAna Pešut
Ana Pešut
MZMarina Zelenika
Marina Zelenika
MDMarija Dorotić
Marija Dorotić
MKMladen Knotek
Mladen Knotek
The net level of immunosuppression in kidney transplant recipients is difficult to assess. QuantiFERON Monitor (QFM) is an in vitro diagnostic test that detects interferon-γ (IFN-γ) release in peripheral blood. The aim of our study was to compare QFM testing results in stable kidney transplant recipients and kidney transplant recipients with infection, in a single-centre cohort. We enrolled 71 kidney transplant recipients from our transplantation centre. They were divided into 2 groups according to clinical presentation (Stable kidney transplant recipients or Infection). There were no significant differences in interferon-γ release between the 2 groups (Stable kidney transplant recipients 140.59 ± 215.28 IU/ml, Infection group 78.37 ± 197.03 IU/ml, P = .24). A further analysis revealed that kidney transplant recipients presenting with bacterial infection had significantly lower IFN-γ release when compared to stable kidney transplant recipients (26.52 ± 42.46 IU/ml vs 140.59 ± 215.28 IU/ml, P = .04). Kidney transplant recipients presenting with bacterial infection had lower IFN-γ release when compared to stable kidney transplant recipients. The QFM test may be useful as a tool to help guide immunosuppression dosing in kidney transplant recipients, but further studies are required to confirm its diagnostic value.

1 January 2020 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
Anna MrzljakAnna Mrzljak
Anna Mrzljak
PKPetra Dinjar Kujundzic
Petra Dinjar Kujundzic
MKMladen Knotek
Mladen Knotek
BKBoris Kudumija
Boris Kudumija
MIMario Ilic
Mario Ilic
Tatjana Vilibic-CavlekTatjana Vilibic-Cavlek
Tatjana Vilibic-Cavlek

15 August 2012 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
DKDragan Klaric
Dragan Klaric
MKMladen Knotek
Mladen Knotek

21 May 2021 in Medicine
Verified
Journal Article
Open access
ZSZrinka Sertić
Zrinka Sertić
TLTomislav Letilović
Tomislav Letilović
TKTajana Filipec Kanižaj
Tajana Filipec Kanižaj
MKMladen Knotek
Mladen Knotek
IHIrzal Hadžibegović
Irzal Hadžibegović
HJHelena Jerkić
Helena Jerkić
Previous studies have demonstrated cardiovascular causes to be among the leading causes of death after liver (LT) and kidney transplantation (KT). Although both recipient populations have unique pre-transplant cardiovascular burdens, they share similarities in post-transplant exposure to cardiovascular risk factors. The aim of this study was to compare cardiovascular mortality after LT and KT. We analyzed causes of death in 370 consecutive LT and 207 KT recipients from in-hospital records at a single tertiary transplant center. Cardiovascular causes of death were defined as cardiac arrest, heart failure, pulmonary embolism, or myocardial infarction. After a median follow-up of 36.5 months, infection was the most common cause of death in both cohorts, followed by cardiovascular causes in KT recipients and graft-related causes in LT recipients in whom cardiovascular causes were the third most common. Cumulative incidence curves for cardiovascular mortality computed with death from other causes as the competing risk were not significantly different (P = .36). While 1-year cumulative cardiovascular mortality was similar (1.6% after LT and 1.5% after KT), the estimated 4-year probability was higher post-KT (3.8% vs. 1.6%). Significant pre-transplant risk factors for overall mortality after KT in multivariable analysis were age at transplantation, left ventricular ejection fraction <50%, and diastolic dysfunction grade 2 or greater, while significant risk factors for cardiovascular mortality were peripheral artery disease and left ventricular ejection fraction <50%. In the LT group no variables remained significant in a multivariable model for either overall or cardiovascular mortality. The present study found no significant overall difference in cardiovascular mortality after LT and KT. While LT and KT recipients may have similar early cardiovascular mortality, long-term risk is potentially lower after LT. Differing characteristics of cardiovascular death between these two patient populations should be further investigated.

17 May 2016 in BMJ Open
Verified
Journal Article
Open access
PDF file
VPVedran Pašara
Vedran Pašara
BMBojana Maksimović
Bojana Maksimović
MGMihaela Gunjača
Mihaela Gunjača
KMKarlo Mihovilović
Karlo Mihovilović
ALAndrea Lončar
Andrea Lončar
MKMladen Knotek
Mladen Knotek
Objectives: Studies have reported that the tunnelled dialysis catheter (TDC) is associated with inferior haemodialysis (HD) patient survival, in comparison with arteriovenous fistula (AVF). Since many cofactors may also affect survival of HD patients, it is unclear whether the greater risk for survival arises from TDC per se , or from associated conditions. Therefore, the aim of this study was to determine, in a multivariate analysis, the long-term outcome of HD patients, with respect to vascular access (VA). Design: Retrospective cohort study. Participants: This retrospective cohort study included all 156 patients with a TDC admitted at University Hospital Merkur, from 2010 to 2012. The control group consisted of 97 patients dialysed via AVF. The groups were matched according to dialysis unit and time of VA placement. The site of choice for the placement of the TDC was the right jugular vein. Kaplan-Meier analysis with log-rank test was used to assess patient survival. Multivariate Cox regression analysis was used to determine independent variables associated with patient survival. Primary outcome measures: Patient survival with respect to VA. Results: The cumulative 1-year survival of patients who were dialysed exclusively via TDC was 86.4% and of those who were dialysed exclusively via AVF, survival was 97.1% (p=0.002). In multivariate Cox regression analysis, male sex and older age were independently negatively associated with the survival of HD patients, while shorter HD vintage before the creation of the observed VA, hypertensive renal disease and glomerulonephritis were positively associated with survival. TDC was an independent risk factor for survival of HD patients (HR 23.0, 95% CI 6.2 to 85.3). Conclusion: TDC may be an independent negative risk factor for HD patient survival.

1 May 2014 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
MKM. Knotek
M. Knotek
KMK. Mihovilović
K. Mihovilović
DLDanica Galešić Ljubanović
Danica Galešić Ljubanović
BMB. Maksimović
B. Maksimović